Previous Record Next Record

Washington State Project to Prevent Prescription Drug / Opioid Overdose

Principal Investigator:
Caleb Banta-Green, PhD, MPH, MSW
Senior Research Scientist, Alcohol and Drug Abuse Institute
Affiliate Associate Professor, School of Public Health

Date: September 1, 2016 to August 31, 2021
Sponsor: Washington State Division of Behavioral Health & Recovery (SP-16-005; (CFDA) NO.: 93.243)
Categories: Overdose Prevention | Prescription Drug Abuse

Other Investigators: Susan Kingston, Program Operations Specialist

Description: The Washington State Project to Prevent Prescription Drug/Opioid Overdose is a statewide network of organizations mobilizing communities, providing overdose response training, and distributing naloxone through syringe exchange programs in four high need areas. Activities engage professional and lay first responders, pharmacies, local and regional stakeholders and health care providers to reduce overdose risk and deaths among people who use heroin and prescription opioids.

The Washington State Project to Prevent Prescription Drug/Opioid Overdose (WA-PDO) will be a collaborative five-year project between the Washington Department of Social and Health Services’ (DSHS) Division of Behavioral Health and Recovery (DBHR) and the University of Washington’s Alcohol and Drug Abuse Institute (ADAI) with the purpose of preventing opioid overdose and deaths from opioid overdose, and building local infrastructure to plan, implement, evaluate, and fund overdose prevention efforts in the long-term. WA-PDO will develop a network of opioid overdose experts and interventions to efficiently extend core overdose prevention expertise and centralized resources at ADAI’s Center for Opioid Safety Education program (COSE) to four diverse, high-need areas (HNA) across the state. With COSE as the central hub and the four regional nodes coordinating WA-PDO overdose prevention activities, WA-PDO will reach adults who use prescription opioids/heroin and professionals and community members who may be the first responders at an overdose. Core interventions include stakeholder engagement, overdose prevention/response training, and naloxone distribution. Objectives include:1) develop overdose prevention strategic plans in four HNAs; 2) equip 2,400 police, fire, and emergency medical services personnel (PFEMS) with overdose response training/naloxone; 3) equip 13,200 lay responders (LR) with overdose response training/naloxone 4) increase naloxone dispensed by pharmacists by 20% each year; 5) educate 1,400 health care providers on opioid guidelines, patient overdose education, and naloxone and opioid use disorders; 6) develop new models of substance use treatment linkage and care coordination in four HNAs; 7) facilitate coordination in four HNAs among local andregional stakeholders and with state agencies; 8) build and harmonize data infrastructures to inform resource allocation, maintain overdose surveillance, and measure outcomes; and 9) create knowledge translation infrastructure to disseminate emerging data, best practices, training, and technical assistance. Over the five-year project, our activities will reach 2,400 PFEMS responders, 13,200 lay responders, 1,400 health care providers, 120 pharmacies, and 160 community organizations across four priority regions.

Related Web Sites: